Current Price: ₹1869.30
Target: ₹2050+
Entry Range: ₹1860 - ₹1885
Stop Loss: Below ₹1800
Indicators & Moving Averages:
The stock is trading above key exponential moving averages (21-day, 50-day, and 200-day), indicating strong momentum and bullish sentiment.
The 21-day EMA crossing above the 50-day EMA suggests an upward trend continuation, especially with the price bouncing from the support levels.
Support & Resistance:
Support: ₹1800, which acts as a critical level to prevent further downside.
Resistance: Around ₹2000 - ₹2050. Once this level is breached, further upside is expected.
Outlook:
Given the strength shown on the chart, with multiple indicators aligning to support the bullish view, Aavas Financiers could see an upward rally, provided market conditions remain favorable. The risk-reward ratio seems promising with a well-defined stop loss, making this a potentially attractive setup for swing traders.
Target: ₹2050+
Entry Range: ₹1860 - ₹1885
Stop Loss: Below ₹1800
Indicators & Moving Averages:
The stock is trading above key exponential moving averages (21-day, 50-day, and 200-day), indicating strong momentum and bullish sentiment.
The 21-day EMA crossing above the 50-day EMA suggests an upward trend continuation, especially with the price bouncing from the support levels.
Support & Resistance:
Support: ₹1800, which acts as a critical level to prevent further downside.
Resistance: Around ₹2000 - ₹2050. Once this level is breached, further upside is expected.
Outlook:
Given the strength shown on the chart, with multiple indicators aligning to support the bullish view, Aavas Financiers could see an upward rally, provided market conditions remain favorable. The risk-reward ratio seems promising with a well-defined stop loss, making this a potentially attractive setup for swing traders.
Started like everyone else — chasing trends, ignoring risk.
Learned the hard way that survival beats prediction.
Now I share structured equity views and hedged options plays using Renko and macro context — built for consistency, not dopamine.
Learned the hard way that survival beats prediction.
Now I share structured equity views and hedged options plays using Renko and macro context — built for consistency, not dopamine.
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。
Started like everyone else — chasing trends, ignoring risk.
Learned the hard way that survival beats prediction.
Now I share structured equity views and hedged options plays using Renko and macro context — built for consistency, not dopamine.
Learned the hard way that survival beats prediction.
Now I share structured equity views and hedged options plays using Renko and macro context — built for consistency, not dopamine.
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。